ArticleBMC cancer2018

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.

Olga Prokopchuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.